Browsing Blizard Institute by Subject "haemophilia A"
Now showing items 1-4 of 4
-
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.
(Wiley Online, 2019-05-07)INTRODUCTION: Standard treatment of congenital haemophilia A is based on replacement therapy with coagulation factor VIII (FVIII) products. A major complication of FVIII therapy is the occurrence of IgG alloantibodies ...